Table:
begin	end	state
1	24	cytoplasmic
25	46	transmembrane
47	51	non-cytoplasmic
52	73	transmembrane
74	91	cytoplasmic
92	113	transmembrane
114	132	non-cytoplasmic
133	154	transmembrane
155	164	cytoplasmic
165	185	transmembrane
186	204	non-cytoplasmic
205	225	transmembrane
226	249	cytoplasmic
250	271	transmembrane
272	295	non-cytoplasmic
296	321	transmembrane
322	340	cytoplasmic
341	362	transmembrane
363	367	non-cytoplasmic
368	391	transmembrane
392	411	cytoplasmic
412	434	transmembrane
435	439	non-cytoplasmic
440	459	transmembrane
460	474	cytoplasmic

Input:
>PfGW456L13_3211
MNENTDRSTDHKGIQLTRALKSRHIFMLSLGGVIGTGLFMGSGVTINQGGPVGAILAYLV
AGFLMYLVMVCLGELSVQMPVSGSFQTHATKYIGPATGFMIGWVYWMSWATTVGLEFTAA
GMLMTRWFPEVPIWYWSALFVVVLFGINAMATRAFGEAEYWFSGIKVAAILGFIVVGVLV
IFGVMPLSSGAPAPMATNLIGDSLFPNGLSAVFAVMMTVVYAFQGCEIMGVAAGETDQPE
KSIPRAVRNVVFRVLIFYVLAIIVLSAIVPWQQAGLMESPFVQVFDMVGIPYAADLMNFV
ILTAILSVGNSGLYASTRILWAMSKTGMAPKSLSPLSKRGVPLRALSITLCFALVSLMTS
FVAADTLFMVLMAVSGMSGTVTWIVIALAQYKFRKAYLRDGGKLRDLKYRAPWFPVLPLM
CITLCCSLFVFLALDETQRPSLYWGFGFIALCYGAYFLIHRKRGAVLAPSLPAA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server